Midazolam	midazolam	O	O
compared	compared	O	O
with	with	O	O
thiopentone	thiopentone	S_chemicals	O
as	as	O	O
an	an	O	O
induction	induction	O	O
agent	agent	O	O
.	.	O	O

In	in	O	O
patients	patients	O	O
premedicated	premedicated	O	O
with	with	O	O
scopolamine	scopolamine	S_chemicals	O
+	+	O	O
morphine	morphine	S_chemicals	O
(	(	B_chemicals	O
+	+	I_chemicals	O
5	5	O	O
mg	mg	O	O
nitrazepam	nitrazepam	S_chemicals	O
the	the	O	O
evening	evening	O	O
before	before	O	O
surgery	surgery	O	O
)	)	O	O
,	,	O	O
the	the	O	O
sleep-inducing	sleep-inducing	O	O
effect	effect	O	O
of	of	O	O
midazolam	midazolam	O	O
0.15	0.15	O	O
mg/kg	mg/kg	O	O
i.v	i.v	O	O
.	.	O	O
was	was	O	O
clearly	clearly	O	O
slower	slower	O	O
in	in	O	O
onset	onset	O	O
than	than	O	O
that	that	O	O
of	of	O	O
thiopentone	thiopentone	S_chemicals	O
4.67	4.67	O	O
mg/kg	mg/kg	O	O
i.v	i.v	O	O
.	.	O	O

Somewhat	somewhat	O	O
fewer	fewer	O	O
cardiovascular	cardiovascular	O	O
and	and	O	O
local	local	O	O
sequelae	sequelae	O	O
were	were	O	O
found	found	O	O
in	in	O	O
the	the	O	O
midazolam	midazolam	O	O
group	group	O	O
,	,	O	O
but	but	O	O
,	,	O	O
although	although	O	O
apnoea	apnoea	O	O
occurred	occurred	O	O
less	less	O	O
often	often	O	O
in	in	O	O
the	the	O	O
midazolam	midazolam	O	O
group	group	O	O
it	it	O	O
lasted	lasted	O	O
longer	longer	O	O
.	.	O	O

On	on	O	O
the	the	O	O
whole	whole	O	O
,	,	O	O
the	the	O	O
differences	differences	O	O
between	between	O	O
midazolam	midazolam	O	O
and	and	O	O
thiopentone	thiopentone	S_chemicals	O
had	had	O	O
no	no	O	O
apparent	apparent	O	O
clinical	clinical	O	O
consequences	consequences	O	O
.	.	O	O

Midazolam	midazolam	O	O
is	is	O	O
a	a	O	O
new	new	O	O
alternative	alternative	O	O
agent	agent	O	O
for	for	O	O
induction	induction	O	O
in	in	O	O
combination	combination	O	O
anaesthesia	anaesthesia	O	O
.	.	O	O

